Putnam BioRevolution ETF (SYNB)

NYSEARCA: SYNB · IEX Real-Time Price · USD
0.00 (0.00%)
Dec 5, 2022 12:00 AM EST - Market open
Assets $4.12M
NAV $27.49
Expense Ratio 0.70%
PE Ratio n/a
Shares Out 150,000
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
1-Year Return n/a
Volume n/a
Open n/a
Previous Close 26.92
Day's Range 26.53 - 27.52
52-Week Low 24.45
52-Week High 27.52
Beta n/a
Holdings 42
Inception Date Sep 29, 2022

About SYNB

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is managed by Putnam.

Asset Class Equity
Stock Exchange NYSEARCA
Ticker Symbol SYNB
Issuer Website Putnam

Top 10 Holdings

50.09% of assets
Name Symbol Weight
Danaher Corporation DHR 7.15%
Eli Lilly and Company LLY 6.18%
Alphabet, Inc. GOOGL 5.89%
Bio-Rad Laboratories, Inc. BIO 5.36%
Thermo Fisher Scientific, Inc. TMO 4.64%
AstraZeneca plc AZN 4.33%
Merck & Co., Inc. MRK 4.33%
Net Cash n/a 4.28%
Avantor, Inc. AVTR 4.20%
Corteva, Inc. CTVA 3.73%
View More Holdings


Putnam Launches 2 Active ETFs Targeting BDCs and Biotechnology

Putnam Investments announced that on Friday, September 30, it will launch two new transparent, actively managed, equity exchange traded funds: the Putnam BDC Income ETF (NYSE Arca: PBDC), concentrating ...

Other symbols: PBDC
2 months ago - ETF Trends

Putnam Investments to Launch Two Innovative Active ETFs

BOSTON--(BUSINESS WIRE)--On Friday, September 30, Putnam Investments will begin to offer two new transparent, actively managed, equity exchange-traded funds (ETFs). The firm will be launching Putnam BDC...

Other symbols: PBDC
2 months ago - Business Wire